The reciprocal interaction of sympathetic nervous system and cAMP-PKA-NF-kB pathway in immune suppression after experimental stroke

Neuroscience Letters

Volumn 627, Issue , 2016, Pages 205-210

  Zuo, Lei ^a   Shi, Luhang ^b   Yan, Fuling ^a  

^a MEDICAL SCHOOL OF SOUTHEAST UNIVERSITY   (China)

^b The First People s Hospital of Lianyungang   (China)

Author keywords

CAMP; Immune depression; NF kB; PKA; Stroke; Sympathetic nervous system

Indexed keywords

BETA ACTIN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; ISOPRENALINE; PROPRANOLOL; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENCEPHALITIS; IMMUNE DEFICIENCY; IMMUNOMODULATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPLEEN; SPLEEN CELL; SURGICAL INJURY; ANIMAL; BLOOD; CEREBRAL ARTERY DISEASE; CEREBROVASCULAR ACCIDENT; IMMUNOLOGY; INFLAMMATION; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; INFARCTION, MIDDLE CEREBRAL ARTERY; INFLAMMATION; INTERLEUKIN-10; MALE; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SPLEEN; STROKE; SYMPATHETIC NERVOUS SYSTEM; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84974829794     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2016.05.066     Document Type: Article

References (32)

1. Johnston S.C., Mendis S., Mathers C.D. Global variation in stroke burden and mortality: estimates from monitoring, surveillance, and modeling. Lancet Neurol. 2009, 8:345-354.
2. Meisel C., Meisel A. Suppressing immunosuppression after stroke. N. Engl. J. Med. 2011, 365:2134-2136.
3. Kumar S., Selim M.H., Caplan L.R. Medical complications after stroke. Lancet Neurol. 2010, 9:105-118.
4. Emsley H.C.A., Hopkins S.J. Acute ischaemic stroke and infection: recent and emerging concepts. Lancet Neurol. 2008, 7:341-353.
5. Tuttolomondo A., Pecoraro R., Pinto A. Studies of selective TNF inhibitors in the treatment of brain injury from stroke and trauma: a review of the evidence to date. Drug Des. Dev. Ther. 2014, 7(November (8)):2221-2238.
6. Iadecola C., Anrather J. The immunology of stroke: from mechanisms to translation. Nat. Med. 2011, 17:796-808.
7. Mehta S.L., Manhas N., Raghubir R. Molecular targets in cerebral ischemia for developing novel therapeutics. Brain Res. Rev. 2007, 54:34-66.
8. Muir K.W., Tyrrell P., Sattar N., Warburton E. Inflammation and ischemic stroke. Curr. Opin. Neurol. 2007, 20:334-342.
9. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J. Neuroimmunol. 2007, 184:53-68.
10. Prass K., Meisel C., Hoflich C., et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by post stroke T helper cell type 1-like immunostimulation. J. Exp. Med. 2003, 198:725-736.
11. Howard R.J., Simmons R.L. Acquired immunologic deficiencies after trauma and surgical procedures. Surg. Gynecol. Obstet. 1974, 139:771-782.
12. Chamorro A., Meisel A., Planas A.M., et al. The immunology of acute stroke. Nat. Rev. Neurol. 2012, 8:401-410.
13. Meisel C., Schwab J.M., Prass K., et al. Central nervous system injury-induced immune deficiency syndrome. Nat. Rev. Neurosci. 2005, 6:775-786.
14. Yan F.L., Zhang J.H. Role of the sympathetic nervous system and spleen inexperimental stroke-induced immunodepression. Med. Sci. Monit. 2014, 20:2489-2496.
15. Gerlo S., Kooijman R., Beck I.M., et al. Cyclic AMP: a selective modulator of NF-kB action. Cell. Mol. Life Sci. 2011, 68:3823-3841.
16. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
17. Gilmore T.D. Introduction to NF-kappa B: players, pathways, perspectives. Oncogene 2006, 25(51):6680-6684.
18. Gilmore T.D., Herscovitch M. Inhibitors of NF-kappa B signaling: 785 and countingInhibitors of NF-kappa B signaling: 785 and counting. Oncogene 2006, 25(51):6887-6899.
19. Meisel A., Smith C.J. Prevention of stroke-associated pneumonia: where next?. Lancet 2015, 386:1802-1804.
20. Westendorp W.F., Vermeij J.D., Zock E., et al. The preventive antibiotics in stroke study (PASS): a pragmatic randomised open-label masked endpoint clinical trial. Lancet 2015, 385:1519-1526.
21. Karin M. Inflammation-activated protein kinases as targets for drug development. Proc. Am. Thorac. Soc. 2005, 2(4). 386-390 discussion 394-385.
22. Bederson J.B., Pitts L.H., Tsuji M., et al. Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 1986, 17:472-476.
23. Kalra L., Irshad S., Hodsoll J., et al. Prophylactic antibiotics after stroke for reducing pneumonia in patients with dysphagia (STROKE-INF): a prospective, cluster-randomised, open-label, masked endpoint, controlled clinical trial. Lancet 2015, 386:1835-1844.
24. McKnight G.S. Cyclic AMP second messenger systems. Curr. Opin. Cell Biol. 1991, 3(2):213-217.
25. Bourne H.R., Lichtenstein L.M., Melmon K.L., et al. Modulation of inflammation and immunity by cyclic AMP. Science 1974, 184(132):19-28.
26. Kammer G.M. The adenylate cyclase-cAMP-protein kinase A pathway and regulation of the immune response. Immunol. Today 1998, 9(7-8):222-229.
27. Zhong H., SuYang H., Erdjument-Bromage H., et al. The transcriptional activity of NF-kappa B is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 1997, 89(3):413-424.
28. Maslov M.Y., Wei A.E., Pezone M.J., et al. Vascular dilation, tachycardia, and increased inotropy occur sequentially with increasing epinephrine dose rate, plasma and myocardial concentrations, and cAMP. Heart Lung Circ. 2015, 24(9):912-918.
29. García-Bonilla L., Benakis C., Moore J., et al. Immune mechanisms in cerebral ischemic tolerance. Front.Neurosci. 2016, 8:44. 10.3389/fnins.2014.00044.
30. Kunz A., Abe T., Hochrainer K., et al. Nuclear factor-kappa B activation and post ischemic inflammation are suppressed in CD36-null mice after middle cerebral artery occlusion. J. Neurosci. 2008, 28:1649-1658.
31. Mracsko E., Liesz A., Karcher S., Zorn M., Bari F., Veltkamp R. Differential effects of sympathetic nervous system and hypothalamic-pituitary-adrenal axis on systemic immune cells after severe experimental stroke. Brain Behav. Immun. 2014, 41:200-209.
32. Romer C., Engel O., Winek K., et al. Blocking stroke-induced immunodeficiency increases CNS antigen-specific autoreactivity but does not worsen functional outcome after experimental stroke. J. Neurosci. 2015, 35(20):7777-7794.